Al-Dawaa stock tests resistance amid trading surge

The share of the Saudi Pharmaceutical Industries Company is testing important resistance levels amid a rise in trading volumes and technical indicators. The stock has maintained support at 28.05 SAR and surpassed the resistance level of 32.00 SAR, with expectations of continuing upward movement toward areas between 33.70 and 34.34 SAR. This outlook is supported by positive technical indicators such as RSI and MACD, despite the presence of key support levels at 30.70 SAR.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل